EP.11D.02 An Investigator-Initiated Phase II Study of Combination Treatment of Nivolumab and TM5614, A PAI-1 Inhibitor for Previously Treated NSCLC

Autor: Masuda, T., Hirata, T., Sakamoto, T., Tsubata, Y., Ichihara, E., Kozuki, T., Shoda, H., Fukagawa, E., Yoshida, T., Fukutani, M., Tsuji-Takayama, K., Orihashi, Y., Hattori, N.

Publikováno v: In Journal of Thoracic Oncology October 2024 19(10) Supplement:S614-S614

Holmium laser enucleation of the prostate as a secondary surgery following prostatic urethral lift.

Autor: Nishino T; Department of Urology St. Luke's International Hospital Chuo-ku Tokyo Japan., Endo F; Department of Urology St. Luke's International Hospital Chuo-ku Tokyo Japan., Nakama D; Department of Urology St. Luke's International Hospital Chuo-ku Tokyo Japan., Sakurai M; Department of Urology St. Luke's International Hospital Chuo-ku Tokyo Japan., Tominaga K; Department of Urology St. Luke's International Hospital Chuo-ku Tokyo Japan., Fukagawa E; Department of Urology St. Luke's International Hospital Chuo-ku Tokyo Japan., Sano M; Department of Urology St. Luke's International Hospital Chuo-ku Tokyo Japan., Narimoto K; Department of Urology St. Luke's International Hospital Chuo-ku Tokyo Japan., Shimbo M; Department of Urology St. Luke's International Hospital Chuo-ku Tokyo Japan., Hattori K; Department of Urology St. Luke's International Hospital Chuo-ku Tokyo Japan.

Publikováno v: IJU case reports [IJU Case Rep] 2023 Oct 28; Vol. 7 (1), pp. 34-37. Date of Electronic Publication: 2023 Oct 28 (Print Publication: 2024).

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

P0607 - The three-dimensional reconstructed virtual images improve the reliability, accuracy, and efficiency of the R.E.N.A.L. nephrometry score for preoperative assessment

Autor: Yoshitomi, K., Komai, Y., Yamamoto, T., Fukagawa, E., Hamada, K., Yoneoka, Y., Fujiwara, M., Fujiwara, R., Oguchi, T., Numao, N., Yuasa, T., Yamamoto, S., Fukui, I., Yonese, J.

Publikováno v: In European Urology June 2021 79 Supplement 1:S829-S830

External validation of the Briganti 2019 nomogram to identify candidates for extended pelvic lymph node dissection among patients with high-risk clinically localized prostate cancer.

Autor: Fukagawa E; Department of Urology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan., Yamamoto S; Department of Urology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan. shinya.yamamoto@jfcr.or.jp., Ohde S; Graduate School of Public Health, St. Luke's International University, 10-1 Akashi-cho, Chuo-ku, Tokyo, 104-0044, Japan., Yoshitomi KK; Department of Urology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan., Hamada K; Department of Urology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan., Yoneoka Y; Department of Urology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan., Fujiwara M; Department of Urology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan., Fujiwara R; Department of Urology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan., Oguchi T; Department of Urology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan., Komai Y; Department of Urology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan., Numao N; Department of Urology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan., Yuasa T; Department of Urology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan., Fukui I; Department of Urology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan., Yonese J; Department of Urology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.

Publikováno v: International journal of clinical oncology [Int J Clin Oncol] 2021 Sep; Vol. 26 (9), pp. 1736-1744. Date of Electronic Publication: 2021 Jun 12.